SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950170-23-055977
Filing Date
2023-10-27
Accepted
2023-10-27 16:05:48
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-1/A ktra-20231027.htm   iXBRL S-1/A 1028741
2 EX-23.1 ktra-ex23_1.htm EX-23.1 5918
3 GRAPHIC img139689720_0.jpg GRAPHIC 9196
4 GRAPHIC img139689720_1.jpg GRAPHIC 9196
  Complete submission text file 0000950170-23-055977.txt   1295345

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ktra-20231027_pre.xml EX-101.PRE 12182
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ktra-20231027.xsd EX-101.SCH 2896
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ktra-20231027_lab.xml EX-101.LAB 14525
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ktra-20231027_def.xml EX-101.DEF 12274
10 EXTRACTED XBRL INSTANCE DOCUMENT ktra-20231027_htm.xml XML 5812
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-1/A | Act: 33 | File No.: 333-274864 | Film No.: 231355541
SIC: 2834 Pharmaceutical Preparations